<DOC>
	<DOCNO>NCT01078714</DOCNO>
	<brief_summary>The purpose study determine treatment bumetanide present efficiency level neuronal maturation autism</brief_summary>
	<brief_title>Efficiency Bumetanide Autistic Children</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Bumetanide</mesh_term>
	<criteria>Children 3 10 year old , answer diagnosis typical autism accord diagnostic criterion autism classification WHO ( CIM10 ) parent give free , enlighten write consent . Patients epileptic autistics treat anticomitiaux hurt central nervous system Patients autistics receive psychotropic treatment Patients present disorder electrolytes Patients present hypersensibility know sulpha drug Presenting patient indication relative treatment bumetanide Patients already treat diuretic Patients present hepatic renal incapacity Patients present elongation QT electrocardiogram . Patients autistics CARS sore low 30 .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Autism</keyword>
	<keyword>Bumetanide</keyword>
	<keyword>GABA</keyword>
	<keyword>NKCC1</keyword>
</DOC>